In June 2025, NOUL signed a distribution agreement with global diagnostic device manufacturer Nihon Kohden for miLab™ BCM blood testing automation system in Mexico. Through this partnership, NOUL’s high-efficiency blood testing platform is expected to enhance diagnostic efficiency and equity across Mexican healthcare settings, marking a significant milestone that could drive meaningful improvements in the country’s blood diagnostics landscape.

 

nihon kohden mexico, noul, noul nihon kohden

Source: noul

 

Current State of Blood Diagnostics in Mexican Healthcare

Mexico is closely connected to the broader Americas region, and with its growing population and rapid urbanization, the demand for healthcare infrastructure and services continues to expand. Among various sectors, the blood diagnostics market has seen particularly rapid development in recent years. Driven by factors such as infectious disease management, chronic illness monitoring, and rising demand for personalized healthcare, the need for blood testing is steadily increasing. To meet this growing demand, there is a pressing need for accurate and efficient diagnostic systems.

 

In Mexico, blood testing is carried out through both private laboratories and public health clinics, with ongoing efforts to improve accessibility. While large private institutions are equipped with automated systems, many regional and smaller hospitals still rely on outdated equipment, making it difficult to keep up with growing demand. Additionally, challenges such as a shortage of skilled personnel, an overburdened public healthcare system, infrastructure imbalances, and regional disparities in medical services continue to limit the consistent delivery of high-quality care.

 

mexico healthcare, mexico diagnosis, mexico clinic, mexico blood test

Source: JRomero04 / Shutterstock

 

The Mexican government is working to address these challenges by adopting innovative technologies. A notable example is the introduction of portable CBC analyzers in certain clinics and emergency rooms, enabling smooth blood testing even in point-of-care (POC) settings. Demand for high-performance POC blood testing devices is growing rapidly, particularly in low-resource areas such as rural regions, emergency outpatient departments, and private clinics—settings where building large-scale medical infrastructure is difficult but access to quality healthcare remains essential.

 

Most blood testing equipment in Mexico is imported, with major hospitals and diagnostic centers widely using systems from global brands such as Sysmex, Beckman Coulter, and Mindray. At the same time, the Mexican healthcare market is striving to build advanced infrastructure by integrating automated testing and data management systems, aiming to improve diagnostic efficiency and meet the growing demand for blood tests nationwide. In line with this trend, global diagnostics company Nihon Kohden Mexico has decided to adopt NOUL’s automation-based blood testing system, miLab™ BCM.

 

 

Strategic Partnership: Nihon Kohden Mexico x NOUL

nihon kohden mexico, noul, noul nihon kohden, nihon kohden

Source: noul

 

Nihon Kohden is a leading Japanese manufacturer of blood testing (CBC) devices, ranking alongside Sysmex and HORIBA at the top of the global hematology diagnostics market. With subsidiaries across the United States, Europe, and Asia, the company supplies its products to over 120 countries worldwide. Among these subsidiaries, Nihon Kohden Mexico—established in 2016—serves as the company’s strategic hub for Latin America (excluding Brazil). It is responsible for the sales and service of medical devices throughout the region and actively contributes to the advancement of medical infrastructure in Mexico through its cutting-edge technologies and products.

 

NOUL is a biohealthcare company focused on developing innovative diagnostic solutions. Through its automated platform for blood-based and cytological tests, miLab™, the company aims to dramatically improve both the accessibility and operational efficiency of blood diagnostics and pathology. NOUL is particularly committed to enabling reliable diagnostic services in low-resource settings and regions lacking diagnostic infrastructure, with a mission to continuously contribute to healthcare equity through technology.

 

 

miLab™ BCM: The Optimal Solution to Revolutionize Blood Diagnostics in Mexico

WBC count in pregnancy, RBC count in pregnancy, pregnancy trimester, normal CBC values

Source: noul

 

The miLab™ BCM is NOUL’s blood analysis solution that uniquely integrates Complete Blood Count (CBC) and Blood Morphology testing, enabling detailed examination of various blood cell types for more accurate analysis. It automates the entire testing process—from staining and analysis to result delivery—within a single cartridge, ensuring consistent and precise results. With a simplified workflow, each test takes approximately 20 minutes, significantly improving both time and labor efficiency.

 

Notably, NOUL’s solid-based staining technology, NGSI (Next Generation Staining & Immunostaining), enhances staining consistency, allowing reliable testing even in settings with limited skilled personnel. Additionally, our on-device AI delivers precise interpretations, supporting high-quality healthcare services in resource-constrained environments.

 

Challenges in Mexico’s Blood Diagnostics EnvironmentmiLab™ BCM
Infrastructure shortageBecause the entire process—from sample preparation to result delivery—can be completed on a single platform, precise blood diagnostic services are accessible not only in large hospitals but also in regional hospitals, public health centers, and primary care facilities.
Shortage of skilled personnelBlood testing requires a high level of expertise, but Mexico faces a shortage of pathologists and specialized hematology technicians. Therefore, miLab™ BCM, which automates the processes of smear preparation, staining, analysis, and interpretation, can reduce the workload on healthcare professionals while delivering quantitative and consistent results in the field.
Increasing Demand for Blood TestingAs the demand for blood testing in Mexico continues to grow, the adoption of more efficient testing methods has become increasingly important. Traditional blood tests required significant time and effort for slide preparation, staining, and microscopic analysis. In contrast, miLab™ BCM completes the entire process—from test preparation to result delivery—in under 20 minutes.
Expansion of Point-of-Care (POC) Testing The portable device automates the entire testing process within a single cartridge, requiring minimal infrastructure while delivering accurate results, making it ideally suited for point-of-care (POC) diagnostics.
Improving Healthcare ServicesThe on-device AI of miLab™ BCM enhances the accuracy of blood morphology analysis by detecting abnormal cells such as atypical cells, blasts, and abnormal white blood cells, thereby contributing to the overall improvement of healthcare services.

 

 

NOUL’s miLab™: Addressing Diagnostic Challenges from a Global Perspective

blood test, blood diagnostic, CBC, blood morphology, LATAM clinic

Source: Shutterstock

 

The agreement with global diagnostics company Nihon Kohden is the result of rigorous performance validation, serving as a significant achievement that proves the capabilities of miLab™ BCM. Moreover, it officially recognizes the product’s market potential on a global scale, adding even greater significance to this milestone. NOUL is also exploring collaborations not only with Nihon Kohden Mexico but with its headquarters and other regions, and this contract is expected to positively influence expansion into additional markets.

 

In March, NOUL announced its entry into the Central American market by signing supply agreements for miLab™ with six countries, including Panama, the Dominican Republic, and Costa Rica. With the recent agreement with Nihon Kohden Mexico, NOUL is set to accelerate its expansion into key Latin American markets. In fact, in June 2025, NOUL completed the registration of the miLab™ platform in Brazil, opening the door to the Brazilian market. The company plans to distribute its products soon in major South American countries to further expand its presence in the region.

 

Ready to transform blood diagnostics in Latin America? Discover how miLab™ BCM is setting new standards in CBC and blood morphology automation.